24
Participants
Start Date
August 5, 2010
Primary Completion Date
March 5, 2013
Study Completion Date
April 19, 2013
RN6G
Intravenous, multiple dose, dose ranging from 5 mg/kg up to a maximum of 15 mg/kg
Placebo
Intravenous, multiple dose with experimental dose
University of Rochester Medical Center, Rochester
University of Rochester, Rochester
Hawthorne Pharmacy, West Columbia
Jay Markowitz and Associates, West Columbia
Palmetto Retina Center, LLC, West Columbia
South Carolina Neurological, West Columbia
Ranjit K. Sethi, MD, PC, Augusta
Clinical Specialists, LLC, Augusta
Southeast Retina Center, PC, Augusta
Retina Associates of Florida, PA, Tampa
Hoye's Pharmacy, Tampa
Specialty Compounding, Cedar Park
Brian B. Berger, MD, PA, Austin
Retina Research Center, PLLC, Austin
Sleep Medicine Consultants, Austin
National Central Pharmacy, Abilene
Abilene Surgery Center, Abilene
Heart and Vascular Institute, Abilene
Retina Research Institute of Texas, Abilene
Retinal Diagnostic Center, Campbell
American Institute of Research (Administrative Only), Los Gatos
Neurology Center Rai Kumar, San Jose
Harmeet Sachdev, MD, FAAN, San Jose
Santa Clara Drug, San Jose
Lead Sponsor
Pfizer
INDUSTRY